Special Issue of International Journal of Gynecology and Obstetrics (IJGO) Published
Women’s Health and Safe Motherhood: Celebrating the Twentieth Anniversary of the Safe Motherhood Initiative
London, 04 October, 2007 - Elsevier is pleased to announce publication of a Special Issue of the International Journal of Gynecology and Obstetrics (IJGO) – the official publication of FIGO (The International Federation of Gynecology and Obstetrics) – to celebrate the twentieth anniversary of the Safe Motherhood Initiative. The Special Issue (Volume 98, No.3 September 2007) has been designed to tie in with the forthcoming international “Women Deliver” conference to be held between 18–20 October, in London, UK.
The September Special Issue contains numerous clinical articles and communications of particular relevance to the issues surrounding women’s health and safe motherhood, both from developed and developing countries. The issue also features articles from the successful Averting Maternal Death and Disability (AMDD) series on topics such as emergency obstetric care in low-resource settings.
The issue includes Special Communications by former FIGO President, Professor Mahmoud Fathalla, and Professor Allan Rosenfield – both leaders in the field of obstetrics and gynecology – who have spearheaded the Safe Motherhood initiative.
A new Special Editorial feature is also launched in the September issue, to introduce prominent FIGO leaders to the readership, and to highlight their special interests and visions for FIGO.
The issue also marks the first publication under the editorship of Timothy R.B. Johnson, M.D., who assumed the role in January 2007. Dr Johnson is the Bates Professor of Diseases of Women and Children, and Chair of the Department of Obstetrics and Gynecology at the University of Michigan, Ann Arbor, USA, and has served on the Editorial Board of the IJGO for several years.
The FIGO Save the Mothers Initiative was launched at the FIGO World Congress of Gynecology & Obstetrics in Copenhagen, Denmark in 1997, and many of its accomplishments have been reported in the pages of the IJGO. The Initiative has now moved on to a second more integrated phase named the “FIGO Saving Mothers & Newborns Initiative”. It utilises FIGO’s unique ability to bring together in a “twinning” process, societies from high resource countries with those in low resource countries to support their identified priorities aligned with the Ministry of Health. The commitment of FIGO to addressing the issues surrounding maternal mortality is highlighted by not only this Initiative – now active in almost a dozen countries around the world – but also by its involvement in ongoing initiatives such as the Prevention of Post Partum Hemorrhage Initiative (POPPHI), the work of its Committees on Safe Motherhood & Newborn Health, Fistula, and Women’s Sexual & Reproductive Rights, as well as its Working Group on The Prevention of Unsafe Abortion.
# # #
Notes to Editors:
Since its inception, the International Journal of Gynecology and Obstetrics has had two primary purposes: (1) to serve an international audience by publishing original scientific articles and communications originating in developing countries, emphasizing the important obstetric and gynecologic problems, issues, and perspectives of the developing world, such as maternal mortality and family planning, as well as publishing original articles and communications from the scientific community of developed countries, with particular emphasis on sharing advances in the specialty of obstetrics and gynecology; and (2) to further the organizational purposes of FIGO by providing a means of bringing to the readership decisions of the Officers and Executive Board, reports of the standing Committees of FIGO, and information from the FIGO Secretariat, in the intervals between meetings of the Executive Board and the international Congresses, and by providing information from the World Health Organization and those other important international organizations that deal with women’s health and the specialty of obstetrics and gynecology.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
+31 20 485 3122